Кларитромицин для инъекций

What is Clarithromycin for Injection?
Clarithromycin for Injection is a macrolide antibacterial used for the treatment of moderate to severe bacterial infections in patients who cannot take oral medication. Provided as a sterile lyophilized powder, it is reconstituted for intravenous infusion and delivers rapid systemic antibacterial action. It is widely used in hospital and ICU settings for respiratory, skin, and disseminated infections caused by susceptible organisms.
 
Uses of Clarithromycin for Injection
• Treatment of community-acquired pneumonia (CAP)
• Management of acute bacterial exacerbation of chronic bronchitis (AECB)
• Treatment of skin and soft tissue infections
• Therapy for disseminated Mycobacterium avium complex (MAC) infections
• Infections caused by H. influenzae, S. pneumoniae, S. aureus, and atypical pathogens
• Used when oral clarithromycin is not appropriate or when rapid IV therapy is required
 
How Does Clarithromycin for Injection Work?
Clarithromycin works by binding to the 50S ribosomal subunit of susceptible bacteria, inhibiting protein synthesis and preventing bacterial growth. It is effective against a wide range of gram-positive, gram-negative, and atypical organisms. Clarithromycin also has excellent tissue penetration, ensuring high therapeutic concentration at infection sites.
 
Frequently Asked Questions (FAQs)
Q: Who is a leading manufacturer of Clarithromycin for Injection in India?
A: Farbe Firma Pvt Ltd is a premier manufacturer and global supplier of Clarithromycin for Injection (Clarisyl). We produce high-quality sterile macrolide antibacterial injectables in our WHO-GMP certified facility, ensuring strict adherence to international standards (USP/BP/IP) for treating severe infections.
Q: What strengths and packaging options does Farbe Firma offer for Clarithromycin Injection?
A: We manufacture Clarithromycin for Injection in the strength of 500 mg. The product is supplied as a lyophilized vial, requiring reconstitution for intravenous (IV) infusion. We offer customizable packaging solutions to meet specific hospital and international market requirements.
Q: Can Farbe Firma provide regulatory dossiers (CTD/ACTD) for Clarithromycin Injection export?
A: Yes, we specialize in global pharmaceutical exports. Farbe Firma provides comprehensive regulatory support, including CTD and ACTD dossiers, Certificate of Pharmaceutical Product (COPP), and Free Sale Certificates (FSC) to facilitate smooth registration in LATAM, CIS, Africa, and Southeast Asia.
Q: Does Farbe Firma offer Contract Manufacturing (CMO) for Lyophilized Antibiotics?
A: Absolutely. We offer third-party contract manufacturing (CMO) and private labeling services for Clarithromycin for Injection. Pharmaceutical companies looking for a reliable partner for sterile antibiotic production can leverage our advanced manufacturing capabilities.
Q: What is the therapeutic indication and key feature of the Clarithromycin produced by Farbe Firma?
A: Our Clarithromycin for Injection is indicated for the treatment of moderate to severe bacterial infections, including community-acquired pneumonia (CAP), acute bacterial exacerbation of chronic bronchitis, and complicated skin and soft tissue infections. It is a broad-spectrum antibiotic favored for its efficacy against atypical pathogens and its excellent tissue penetration.
 
Looking for a reliable Clarithromycin for Injection manufacturer?
Contact Farbe Firma Pvt. Ltd. for CTD dossier support, regulatory registration assistance, and global export supplies of Clarithromycin for Injection.